A Primary Care NP Is Considering Using a Topical Immunosuppressive

A primary care NP is considering using a topical immunosuppressive agent for a patient who has atopic dermatitis that is refractory to treatment with topical corticosteroids.The NP should:

A) begin therapy with pimecrolimus (Elidel) .
B) tell the patient that these agents may be used long-term.
C) counsel the patient that these agents are more likely to cause skin atrophy.
D) tell the patient that laboratory monitoring for hypothalamic-pituitary-adrenal (HPA) suppression will be necessary.